Numinus Wellness, Inc. (NUMIF)
0.0278
-0.01
(-17.75%)
USD |
OTCM |
Sep 08, 16:00
Numinus Wellness Profit Margin (Quarterly) : -16.07% for May 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -16.07% |
| February 28, 2026 | -5.74% |
| November 30, 2025 | -11.89% |
| August 31, 2025 | |
| May 31, 2025 | -37.09% |
| February 28, 2025 | -620.3% |
| November 30, 2024 | -51.86% |
| August 31, 2024 | -155.3% |
| May 31, 2024 | -390.7% |
| February 29, 2024 | -589.2% |
| November 30, 2023 | -314.6% |
| August 31, 2023 | -152.3% |
| May 31, 2023 | -133.7% |
| Date | Value |
|---|---|
| February 28, 2023 | -136.9% |
| November 30, 2022 | -111.1% |
| August 31, 2022 | -590.9% |
| May 31, 2022 | -945.7% |
| February 28, 2022 | -997.0% |
| November 30, 2021 | -678.1% |
| August 31, 2021 | -1.59K% |
| May 31, 2021 | -858.3% |
| February 28, 2021 | -1.83K% |
| November 30, 2020 | -841.6% |
| August 31, 2020 | -1.21K% |
| May 31, 2020 | -1.54K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.01K% |
| Edesa Biotech, Inc. | -- |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 164.2% |
| Gross Profit Margin (Quarterly) | 51.16% |
| Operating Margin (Quarterly) | -14.91% |
| Return on Net Operating Assets | 205.8% |